The website for professionals in Laboratory Medicine

NEWS

Drones set to revolutionise NHS pathology deliveries in Lancashire and South Cumbria

Drones set to revolutionise NHS pathology deliveries in Lancashire and South Cumbria

The NHS in Lancashire and South Cumbria is set to pioneer the use of drone technology to deliver medical samples between selected hospital sites thanks to around £1.4m in UK Research and Innovation funding.

University Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT) and Lancashire Teaching Hospitals NHS Foundation Trust will be teaming up with local enterprises Digital & Future Technologies and Miralis Data Limited to deliver the 20-month project.

Selected as part of the government’s Future Flight Challenge, the two-phase trial will first see medical samples being transported between the Royal Lancaster Infirmary, Westmorland General and Furness General Hospital before simulating the potential expansion to Royal Preston Hospital.

The electrically charged drones will cut the delivery times between the hospitals across Morecambe Bay by over an hour, optimising the operation of pathology labs, meaning patients and clinicians will have access to results faster. Currently samples travel between the hospitals by van multiple times per day, with the new technology set to reduce the carbon footprint as part of the health service’s wider green agenda.

The drones, developed by UK company SkyLift UAV, will operate specific routes across the bay between the hospitals, for a trial period of 90 days and will fly almost silently in their own dedicated airspace at 250 feet above ground level. This comes thanks to support from the Civil Aviation Authority and co-operation from large private sector organisations.

Phil Woodford, director of corporate affairs at UHMBT, said: “We live and work in one of the most beautiful parts of the country and we have a responsibility to do so in as safe and sustainable way as possible. It typically takes anything from 60-90 minutes to drive a van between the RLI and FGH whilst spewing out pollutants that damage the atmosphere and our health. Travel time door to door with the drone will be achieved in around 15-20 minutes - slashing the normal time by up to 70%. It also has the potential to aid clinical decision making with the removal of unnecessary transport delays.”

Professor Anthony Rowbottom MBE, clinical director for pathology at Lancashire Teaching Hospitals, added: “This important project will revolutionise deliveries across a specific part of Lancashire and South Cumbria and provide valuable insight into how this can be expanded across a larger pathology partnership network.

“Not only will this expedite the transfer of patient samples but if successful could provide scope for branching into other NHS services and, in the not-too-distant future, should be seen as standard practice. In the long term, with the right ambition and direction, why not aspire towards potentially extending drone use to home delivery for patients.”

FEATURES

Placental growth factor: supporting management of pre-eclampsia

Although the exact cause of pre-eclampsia is not known, it is thought to occur when a problem develops with the placenta. Routine blood pressure and proteinuria checks are performed during the antenatal period to detect this condition, and can now be complemented by the addition of near-patient placental growth factor testing.

Molecular detection of Mycobacterium ulcerans strains in Nigeria

Mycobacterium ulcerans infection results in a debilitating disease that is characterised by extensive and severe destruction of the skin and subcutaneous tissue. Adewale Oke and colleagues report on a study that aimed to identify cases of so-called Buruli ulcer in five states of south-west Nigeria.

CliniSys and its national conference: back, live to shape the future

The CliniSys national conference returned to The Belfry after a two-year hiatus to debate the big challenges facing the NHS and its pathology services. Matthew Fouracre reports.

Innovation Lab supports Newcastle University study into new COVID-19 test

The North East Innovation Lab works to assess and accelerate the development of new diagnostic tests. Pathology in Practice looks at the support it provided to a study assessing the use of synthetic polymer antibodies in a new test for SARS-CoV-2.

PRODUCTS

LATEST ISSUEs

August 2022
January 2022
September 2020

Upcoming Events

Point of Care: Innovations

The Bristol - Harbourside (Doyle Collection) hotel
20 September 2022

Arab Lab Live 2022

Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022

Lab Innovations 2022

Hall 2 NEC, Birmingham
2 & 3 November 2022

MEDICA 2022

Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022

Meeting demand: the changing picture of diagnostics

The King's Fund, London, W1G 0AN
16 November 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Point of Care: Innovations

The Bristol - Harbourside (Doyle Collection) hotel
20 September 2022

Arab Lab Live 2022

Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022

Lab Innovations 2022

Hall 2 NEC, Birmingham
2 & 3 November 2022

MEDICA 2022

Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022

Meeting demand: the changing picture of diagnostics

The King's Fund, London, W1G 0AN
16 November 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025